For best experience please turn on javascript and use a modern browser!
Bekijk de site in het Nederlands

Chronic lymphocytic leukemia (CLL) is the most frequently occurring adult blood cancer in Western countries. The research conducted by Rachel Thijssen focuses on the signaling pathways that are important for the survival of CLL cells in the microenvironment and how the responsible signaling pathways can be inhibited. Insight into the signaling pathways is important for the development of new treatment strategies for CLL.

Event details of Signaling pathways in leukemia cells
Date 25 November 2016
Time 14:00
Location Agnietenkapel
Room Location

Mw. R. Thijssen: The Interplay between Microenvironmental Signaling and Novel Targeted Drugs in CLL

Promotoren zijn prof. dr. A.P. Kater en prof. dr. E.F. Eldering. Copromotor is prof. dr. M.J. Kersten.


Prof. A.P. Kater
Prof. E.F. Eldering


Prof. M.J. Kersten

Dr D.K. Kaawa-Mafigiri (Makerere University)


Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam


This event is open to the public.